KPV Dosage, Reconstitution & Mixing Trends

Explore kpv calculator-entry dose, vial-size, BAC-water and self-reported frequency distributions. Research context is separate from live observations.

Anonymized kpv calculator entries are summarized by each chart's selected period. Frequency responses come from the separate vial-duration feature. Inputs are not verified administrations or unique people.

What KPV Is

KPV is an anti-inflammatory research peptide most often sourced for gut and skin protocols, frequently paired with BPC-157. It ships as a lyophilized powder you reconstitute with bacteriostatic water (and is sometimes used in oral or topical form).[1]

KPV diffuses across cell membranes and acts intracellularly to inhibit NF-κB nuclear translocation and downstream pro-inflammatory cytokine transcription (TNF-α, IL-6, IL-8). Unlike α-MSH, KPV does not require melanocortin-receptor binding for its anti-inflammatory effect, which is consistent with its activity in MC1R-knockout models.[2]

Pre-clinical work has focused on inflammatory bowel disease — orally and rectally administered KPV reduced colitis severity in DSS and TNBS mouse models and ex-vivo human colonic biopsies — and on atopic dermatitis and psoriasiform skin inflammation.[3] No randomized human trials have been published; clinical interest persists in IBD adjuvant therapy and topical dermatology formulations.

Not FDA-approved for any indication. Sold as a research peptide and as a cosmetic ingredient in some topical formulations.

KPV Research Sources

KPV Dosing Context

KPV has a reported half-life of ~1 hour. The pharmacokinetic reference models an interval of once daily; this is not a measured community cadence or a dosing recommendation. Short half-life — each daily dose clears well before the next, so the working effect is essentially per-dose with no systemic accumulation. Pharmacokinetic source: Pre-clinical α-MSH fragment pharmacokinetic studies. It is catalogued under Skin Peptides on WPA.

KPV Community Calculator Data

7,746 KPV reconstitution calculations have been logged by the WPA community.

This is the lifetime header population. Each chart and its associated analysis below use their own selected period and denominator; frequency responses are a separate cohort.

These figures come from anonymized WPA peptide calculator sessions, not verified administrations or unique people. Separate modal inputs do not establish a joint protocol. They are community input statistics — not dosing recommendations, and not medical advice.

WPA Analysis

KPV Research Background and Calculator Data

KPV is the C-terminal tripeptide fragment of alpha-melanocyte-stimulating hormone — a three-amino-acid sequence (lysine-proline-valine, residues 11-13 of α-MSH) that the Lipton and Catania programs at the University of New Mexico and Sapienza University of Rome characterized across the 1990s and early 2000s as the structural region responsible for α-MSH's anti-inflammatory and immunomodulatory effects. The original observation was that the full α-MSH peptide produced both pigmentation effects (via the MC1 receptor) and a separate, distinct anti-inflammatory effect, and that the anti-inflammatory portion was preserved in the KPV fragment without any pigmentation activity — making it the cleanest possible chemical probe for the inflammation arm of the α-MSH biology. The downstream preclinical literature established KPV as a broad-spectrum anti-inflammatory active in colitis models, asthma models, and inflammatory skin conditions in rodents, with proposed mechanisms involving NF-κB inhibition, IL-1 and TNF-α suppression, and direct effects on inflammatory cell migration. The Mark Donowitz / PepTx human-trial program in inflammatory bowel disease produced an oral KPV formulation that advanced into early-phase clinical study, and an aerosolized KPV product (AP102) reached early clinical evaluation in respiratory inflammation. Neither program has produced a labeled human therapeutic indication, but the controlled clinical safety record on KPV is meaningfully deeper than on most healing peptides on this site — though, importantly, all of that clinical exposure is on oral or topical formulations, not on subcutaneous injectable preparations.

Research background is separate from the calculator observations below. Calculator entries do not establish administration, safety, effectiveness, or the reasons for an input.

WPA DOSING INSIGHT

Dose and Frequency Calculator Inputs

The summaries use each chart's own period and, for frequency responses, its dose filter. Separate cohorts must not be combined into a protocol.

WPA RECONSTITUTION INSIGHT

Vial Size and BAC Water Calculator Inputs

Vial-size and BAC-water observations describe separate input distributions, not purchases or verified preparations. Separate modal inputs do not establish a joint protocol.

These figures come from anonymized WPA peptide calculator sessions.

All figures shown are aggregated from anonymized calculator inputs and are provided strictly for independent laboratory research and educational purposes. They are community usage statistics — not dosing recommendations, and not medical advice.